Research Partner

As part of the Helmholtz Drug Research, six of Germany's Helmholtz centres from the fields of health research and key technologies have joined forces with three non-Helmholtz affiliates:

Druck-Version

News

13. January 2020

Significant steps taken in the development of potential new cancer treatments

Together with the European Lead Factory (ELF), scientists from the German Cancer Research Center (DKFZ) have successfully discovered potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases. Published in ChemMedChem, the findings mark a significant step in the development of potential new cancer treatments.

more information

10. January 2020

POSTPONED! HDDC 2020: 3rd Helmholtz Drug Discovery Conference